NovoCure Beheer
Beheer criteriumcontroles 3/4
NovoCure's CEO is Asaf Danziger, appointed in Jan 2002, has a tenure of 22.83 years. total yearly compensation is $1.52M, comprised of 49.7% salary and 50.3% bonuses, including company stock and options. directly owns 0.014% of the company’s shares, worth R$1.45M. The average tenure of the management team and the board of directors is 2.6 years and 7 years respectively.
Belangrijke informatie
Asaf Danziger
Algemeen directeur
US$1.5m
Totale compensatie
| Percentage CEO-salaris | 49.7% |
| Dienstverband CEO | 22.8yrs |
| Eigendom CEO | 0.01% |
| Management gemiddelde ambtstermijn | 2.6yrs |
| Gemiddelde ambtstermijn bestuur | 7yrs |
Recente managementupdates
Recent updates
Analyse CEO-vergoeding
| Datum | Totale vergoeding | Salaris | Bedrijfswinsten |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | -US$150m |
| Jun 30 2024 | n/a | n/a | -US$169m |
| Mar 31 2024 | n/a | n/a | -US$193m |
| Dec 31 2023 | US$2m | US$756k | -US$207m |
| Sep 30 2023 | n/a | n/a | -US$197m |
| Jun 30 2023 | n/a | n/a | -US$174m |
| Mar 31 2023 | n/a | n/a | -US$141m |
| Dec 31 2022 | US$2m | US$831k | -US$93m |
| Sep 30 2022 | n/a | n/a | -US$82m |
| Jun 30 2022 | n/a | n/a | -US$68m |
| Mar 31 2022 | n/a | n/a | -US$59m |
| Dec 31 2021 | US$1m | US$876k | -US$58m |
| Sep 30 2021 | n/a | n/a | -US$27m |
| Jun 30 2021 | n/a | n/a | -US$5m |
| Mar 31 2021 | n/a | n/a | US$12m |
| Dec 31 2020 | US$9m | US$782k | US$20m |
| Sep 30 2020 | n/a | n/a | US$19m |
| Jun 30 2020 | n/a | n/a | US$12m |
| Mar 31 2020 | n/a | n/a | US$9m |
| Dec 31 2019 | US$7m | US$702k | -US$7m |
| Sep 30 2019 | n/a | n/a | -US$27m |
| Jun 30 2019 | n/a | n/a | -US$41m |
| Mar 31 2019 | n/a | n/a | -US$55m |
| Dec 31 2018 | US$5m | US$693k | -US$64m |
| Sep 30 2018 | n/a | n/a | -US$59m |
| Jun 30 2018 | n/a | n/a | -US$59m |
| Mar 31 2018 | n/a | n/a | -US$64m |
| Dec 31 2017 | US$4m | US$698k | -US$62m |
Compensatie versus markt: Asaf's total compensation ($USD1.52M) is above average for companies of similar size in the BR market ($USD800.78K).
Compensatie versus inkomsten: Asaf's compensation has been consistent with company performance over the past year.
CEO
Asaf Danziger (58 yo)
22.8yrs
Tenure
US$1,521,026
Compensatie
Mr. Asaf Danziger is a Director at Airway Therapeutics, Inc. since April 2020. He has been the Chief Executive Officer of Novocure Limited since 2002 and its Director since 2012 respectively and also serve...
Leiderschapsteam
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| Executive Chairman | 20.8yrs | US$1.43m | 0.51% R$ 52.3m | |
| CEO & Director | 22.8yrs | US$1.52m | 0.014% R$ 1.4m | |
| Chief Financial Officer | 4.2yrs | US$6.32m | 0.085% R$ 8.7m | |
| General Counsel | 2.6yrs | US$4.86m | 0.019% R$ 2.0m | |
| Executive VP & President of Novocure Oncology | 4.2yrs | US$5.04m | 0.053% R$ 5.4m | |
| Founder & CTO | 24.8yrs | US$282.51k | geen gegevens | |
| Chief Operating Officer | less than a year | geen gegevens | 0.0034% R$ 348.4k | |
| Chief Science Officer | 1.8yrs | geen gegevens | 0.0065% R$ 665.9k | |
| VP of Investor Relations | no data | geen gegevens | geen gegevens | |
| Chief Human Resources Officer | 1.2yrs | geen gegevens | 0.0016% R$ 164.4k | |
| Chief Innovation Officer | 1.8yrs | geen gegevens | 0.057% R$ 5.9m | |
| Senior VP | no data | geen gegevens | geen gegevens |
2.6yrs
Gemiddelde duur
54.5yo
Gemiddelde leeftijd
Ervaren management: N2VC34's management team is considered experienced (2.6 years average tenure).
Bestuursleden
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| Executive Chairman | 20.8yrs | US$1.43m | 0.51% R$ 52.3m | |
| CEO & Director | 12.8yrs | US$1.52m | 0.014% R$ 1.4m | |
| Independent Director | 6.3yrs | US$446.09k | 0.0023% R$ 240.5k | |
| Independent Director | 6.5yrs | US$426.09k | 0.0084% R$ 868.4k | |
| Independent Director | 3.8yrs | US$448.53k | 0.0036% R$ 373.0k | |
| Independent Director | 13.1yrs | US$435.53k | 0.073% R$ 7.5m | |
| Lead Independent Director | 18.8yrs | US$475.53k | 0.15% R$ 15.3m | |
| Independent Director | 7.5yrs | US$446.09k | 0.014% R$ 1.5m | |
| Independent Director | 1.7yrs | US$696.94k | 0% R$ 0 | |
| Independent Director | 1.8yrs | US$697.26k | 0% R$ 0 |
7.0yrs
Gemiddelde duur
62yo
Gemiddelde leeftijd
Ervaren bestuur: N2VC34's board of directors are considered experienced (7 years average tenure).